Bejelentkezés Regisztrálj ingyen

Accelerate Diagnostics Inc Ret. a saját tőke

Mi az Accelerate Diagnostics Inc Ret. a saját tőke?

A Ret. a saját tőke az Accelerate Diagnostics Inc - 131.18%

Mi a Ret. a saját tőke meghatározása?



A saját tőke megtérülése egy vállalkozás nyereségességének mértéke a részvényes saját tőkéjének könyv szerinti értékéhez viszonyítva. Ezt úgy számítják ki, hogy a pénzügyi év nettó eredményét a teljes részvényes tőkével osztják el.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Ret. a saját tőke a Health Care szektor a NASDAQ-on cégekben a Accelerate Diagnostics Inc -hoz képest

Mit csinál Accelerate Diagnostics Inc?

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

ret. a saját tőke -hoz hasonló cégek Accelerate Diagnostics Inc